Seetharama D. Jois

The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

Farhana Musarrat, Vladimir N. Chouljenko, Achyut Dahal et al. · Journal of Medical Virology · 2020 · 158 citations · Full text

Covid‐19 Infections, Immunodeficiencies, Viral Pathogenesis +20

An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells

Mohammad B. Uddin, Kartik R. Roy, Salman B. Hosain et al. · Biochemical Pharmacology · 2018 · 108 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +8

Peptides Derived from Human Decorin Leucine-rich Repeat 5 Inhibit Angiogenesis

Konerirajapuram Natarajan Sulochana, Huapeng Fan, Seetharama D. Jois et al. · Journal of Biological Chemistry · 2005 · 83 citations · Full text

Immunology, Peptide Science, Endothelial Cell Attachment +17

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohamed M. Mohyeldin et al. · Pharmacological Research · 2020 · 80 citations · Full text

Breast Oncology, Hormonal Receptor, Immunology +9

Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells

Ning Zhao, Tyrslai M. Williams, Zehua Zhou et al. · Bioconjugate Chemistry · 2017 · 63 citations · Full text